New Insights into Measles Virus Brain Infections

Trends in Microbiology

Volumn 27, Issue 2, 2019, Pages 164-175

  Watanabe, Shumpei ^a,b   Shirogane, Yuta ^a   Sato, Yuma ^a   Hashiguchi, Takao ^a   Yanagi, Yusuke ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY OF SCIENCE   (Japan)

Author keywords

CNS; fusion; measles virus; MIBE; paramyxovirus; SSPE

Indexed keywords

ANTIBIOTIC AS 48; FUSION PROTEIN; VIRAL PROTEIN; VIRUS FUSION INHIBITOR; VIRUS FUSION PROTEIN;

BRAIN INFECTION; CELL SPREADING; CRYSTAL STRUCTURE; HUMAN; MEASLES; MEASLES VIRUS; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STABILITY; PROTEIN STRUCTURE; REVIEW; SUBACUTE SCLEROSING PANENCEPHALITIS; AMINO ACID SUBSTITUTION; ANIMAL; BRAIN; CHEMISTRY; PATHOGENICITY; PROTEIN CONFORMATION; VIROLOGY;

AMINO ACID SUBSTITUTION; ANIMALS; BRAIN; HUMANS; MEASLES; MEASLES VIRUS; NEURONS; PROTEIN CONFORMATION; SUBACUTE SCLEROSING PANENCEPHALITIS; VIRAL FUSION PROTEINS;

EID: 85053156529     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2018.08.010     Document Type: Review

References (73)

1. Griffin, D., et al. Measles virus. Knipe, D., (eds.) Fields Virology, 6th edn, 2013, Lippincott Williams & Wilkins, 1042–1069.
2. Coughlin, M.M., et al. Perspective on global measles epidemiology and control and the role of novel vaccination strategies. Viruses, 9, 2017, E11.
3. Bellini, W.J., et al. Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized. J. Infect. Dis. 192 (2005), 1686–1693.
4. Schonberger, K., et al. Epidemiology of subacute sclerosing panencephalitis (SSPE) in Germany from 2003 to 2009: a risk estimation. PLoS One, 8, 2013, e68909.
5. Gutierrez, J., et al. Subacute sclerosing panencephalitis: an update. Dev. Med. Child Neurol. 52 (2010), 901–907.
6. Hashiguchi, T., et al. Structures of the prefusion form of measles virus fusion protein in complex with inhibitors. Proc. Natl. Acad. Sci. U. S. A. 115 (2018), 2496–2501.
7. Hashiguchi, T., et al. Structure of the measles virus hemagglutinin bound to its cellular receptor SLAM. Nat. Struct. Mol. Biol. 18 (2011), 135–141.
8. Plattet, P., et al. Measles virus fusion protein: structure, function and inhibition. Viruses, 8, 2016, 112.
9. Plemper, R.K., et al. Structural and mechanistic studies of measles virus illuminate paramyxovirus entry. PLoS Pathog., 7, 2011, e1002058.
10. Yanagi, Y., et al. Measles virus receptors. Griffin, D.E., Oldstone, M.B.A., (eds.) Measles, 2009, Springer, 13–30.
11. Bose, S., et al. Timing is everything: fine-tuned molecular machines orchestrate paramyxovirus entry. Virology 479/480 (2015), 518–531.
12. Tatsuo, H., et al. SLAM (CDw150) is a cellular receptor for measles virus. Nature 406 (2000), 893–897.
13. Noyce, R.S., Richardson, C.D., Nectin 4 is the epithelial cell receptor for measles virus. Trends Microbiol. 20 (2012), 429–439.
14. Muhlebach, M.D., et al. Adherens junction protein nectin-4 is the epithelial receptor for measles virus. Nature 480 (2011), 530–533.
15. Baczko, K., et al. Clonal expansion of hypermutated measles virus in a SSPE brain. Virology 197 (1993), 188–195.
16. Baricevic, M., et al. A comparison of complete untranslated regions of measles virus genomes derived from wild-type viruses and SSPE brain tissues. Virus Genes 35 (2007), 17–27.
17. Cattaneo, R., et al. Altered transcription of a defective measles virus genome derived from a diseased human brain. EMBO J. 6 (1987), 681–688.
18. Cattaneo, R., et al. Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell 55 (1988), 255–265.
19. Homma, M., et al. Isolation and characterization of subacute sclerosing panencephalitis virus (Yamagata-1 strain) from a brain autopsy. Microbiol. Immunol. 26 (1982), 1195–1202.
20. Hotta, H., et al. Full-length sequence analysis of subacute sclerosing panencephalitis (SSPE) virus, a mutant of measles virus, isolated from brain tissues of a patient shortly after onset of SSPE. Microbiol. Immunol. 50 (2006), 525–534.
21. Makino, S., et al. Isolation and biological characterization of a measles virus-like agent from the brain of an autopsied case of subacute sclerosing panencephalitis (SSPE). Microbiol. Immunol. 21 (1977), 193–205.
22. Moulin, E., et al. Molecular characterization of measles virus strains causing subacute sclerosing panencephalitis in France in 1977 and 2007. J. Med. Virol. 83 (2011), 1614–1623.
23. Ning, X., et al. Alterations and diversity in the cytoplasmic tail of the fusion protein of subacute sclerosing panencephalitis virus strains isolated in Osaka, Japan. Virus Res. 86 (2002), 123–131.
24. Schmid, A., et al. Subacute sclerosing panencephalitis is typically characterized by alterations in the fusion protein cytoplasmic domain of the persisting measles virus. Virology 188 (1992), 910–915.
25. Seki, F., et al. The SI strain of measles virus derived from a patient with subacute sclerosing panencephalitis possesses typical genome alterations and unique amino acid changes that modulate receptor specificity and reduce membrane fusion activity. J. Virol. 85 (2011), 11871–11882.
26. Schneider-Schaulies, J., et al. Measles infection of the central nervous system. J. Neurovirol. 9 (2003), 247–252.
27. Ayata, M., et al. Mutations affecting transcriptional termination in the p gene end of subacute sclerosing panencephalitis viruses. J. Virol. 76 (2002), 13062–13068.
28. Cathomen, T., et al. A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. EMBO J. 17 (1998), 3899–3908.
29. Cathomen, T., et al. Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence. J. Virol. 72 (1998), 1224–1234.
30. Tahara, M., et al. Altered interaction of the matrix protein with the cytoplasmic tail of hemagglutinin modulates measles virus growth by affecting virus assembly and cell–cell fusion. J. Virol. 81 (2007), 6827–6836.
31. Wiener, D., et al. Synergistic inhibition in cell–cell fusion mediated by the matrix and nucleocapsid protein of canine distemper virus. Virus Res. 129 (2007), 145–154.
32. Dorig, R.E., et al. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75 (1993), 295–305.
33. Manchester, M., et al. Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus. Proc. Natl. Acad. Sci. U. S. A. 91 (1994), 2161–2165.
34. Naniche, D., et al. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J. Virol. 67 (1993), 6025–6032.
35. Kemper, C., Atkinson, J.P., Measles virus and CD46. Griffin, D.E., Oldstone, M.B.A., (eds.) Measles, 2009, Springer, 31–57.
36. Bitnun, A., et al. Measles inclusion-body encephalitis caused by the vaccine strain of measles virus. Clin. Infect. Dis. 29 (1999), 855–861.
37. Campbell, H., et al. Review of the effect of measles vaccination on the epidemiology of SSPE. Int. J. Epidemiol. 36 (2007), 1334–1348.
38. McQuaid, S., Cosby, S.L., An immunohistochemical study of the distribution of the measles virus receptors, CD46 and SLAM, in normal human tissues and subacute sclerosing panencephalitis. Lab. Invest. 82 (2002), 403–409.
39. Reymond, N., et al. Nectin4/PRR4, a new afadin-associated member of the nectin family that trans-interacts with nectin1/PRR1 through V domain interaction. J. Biol. Chem. 276 (2001), 43205–43215.
40. Watanabe, S., et al. Mutant fusion proteins with enhanced fusion activity promote measles virus spread in human neuronal cells and brains of suckling hamsters. J. Virol. 87 (2013), 2648–2659.
41. Shirogane, Y., et al. Cooperation between different RNA virus genomes produces a new phenotype. Nat. Commun., 3, 2012, 1235.
42. Doyle, J., et al. Two domains that control prefusion stability and transport competence of the measles virus fusion protein. J. Virol. 80 (2006), 1524–1536.
43. Hull, J.D., et al. Resistance of a measles virus mutant to fusion inhibitory oligopeptides is not associated with mutations in the fusion peptide. Virology 159 (1987), 368–372.
44. Plemper, R.K., Compans, R.W., Mutations in the putative HR-C region of the measles virus F2 glycoprotein modulate syncytium formation. J. Virol. 77 (2003), 4181–4190.
45. Plemper, R.K., et al. A target site for template-based design of measles virus entry inhibitors. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 5628–5633.
46. Plemper, R.K., et al. Structural features of paramyxovirus F protein required for fusion initiation. Biochemistry 42 (2003), 6645–6655.
47. Rota, J.S., et al. Genetic variability of the glycoprotein genes of current wild-type measles isolates. Virology 188 (1992), 135–142.
48. Ayata, M., et al. The F gene of the Osaka-2 strain of measles virus derived from a case of subacute sclerosing panencephalitis is a major determinant of neurovirulence. J. Virol. 84 (2010), 11189–11199.
49. Jurgens, E.M., et al. Measles fusion machinery is dysregulated in neuropathogenic variants. mBio, 6, 2015 e02528-14.
50. Watanabe, S., et al. Measles virus mutants possessing the fusion protein with enhanced fusion activity spread effectively in neuronal cells, but not in other cells, without causing strong cytopathology. J. Virol. 89 (2015), 2710–2717.
51. Harrison, S.C., Viral membrane fusion. Virology 479/480 (2015), 498–507.
52. Avila, M., et al. Molecular determinants defining the triggering range of prefusion F complexes of canine distemper virus. J. Virol. 88 (2014), 2951–2966.
53. Sergel, T.A., et al. A single amino acid change in the Newcastle disease virus fusion protein alters the requirement for HN protein in fusion. J. Virol. 74 (2000), 5101–5107.
54. Plemper, R.K., et al. Design of a small-molecule entry inhibitor with activity against primary measles virus strains. Antimicrob. Agents Chemother. 49 (2005), 3755–3761.
55. Richardson, C.D., et al. Specific inhibition of paramyxovirus and myxovirus replication by oligopeptides with amino acid sequences similar to those at the N-termini of the F1 or HA2 viral polypeptides. Virology 105 (1980), 205–222.
56. Sato, Y., et al. Cell-to-cell measles virus spread between human neurons is dependent on hemagglutinin and hyperfusogenic fusion protein. J. Virol., 92, 2018 e02166-17.
57. Singh, B.K., et al. The nectin-4/afadin protein complex and intercellular membrane pores contribute to rapid spread of measles virus in primary human airway epithelia. J. Virol. 89 (2015), 7089–7096.
58. Alves, L., et al. SLAM- and nectin-4-independent noncytolytic spread of canine distemper virus in astrocytes. J. Virol. 89 (2015), 5724–5733.
59. Lawrence, D.M., et al. Measles virus spread between neurons requires cell contact but not CD46 expression, syncytium formation, or extracellular virus production. J. Virol. 74 (2000), 1908–1918.
60. Ehrengruber, M.U., et al. Measles virus spreads in rat hippocampal neurons by cell-to-cell contact and in a polarized fashion. J. Virol. 76 (2002), 5720–5728.
61. Young, V.A., Rall, G.F., Making it to the synapse: measles virus spread in and among neurons. Curr. Top. Microbiol. Immunol. 330 (2009), 3–30.
62. Lambert, D.M., et al. Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proc. Natl. Acad. Sci. U. S. A. 93 (1996), 2186–2191.
63. Wild, T.F., Buckland, R., Inhibition of measles virus infection and fusion with peptides corresponding to the leucine zipper region of the fusion protein. J. Gen. Virol. 78 (1997), 107–111.
64. Gomes, B., et al. Biophysical properties and antiviral activities of measles fusion protein derived peptide conjugated with 25-hydroxycholesterol. Molecules, 22, 2017, E1869.
65. Mathieu, C., et al. Prevention of measles virus infection by intranasal delivery of fusion inhibitor peptides. J. Virol. 89 (2015), 1143–1155.
66. Welsch, J.C., et al. Fatal measles virus infection prevented by brain-penetrant fusion inhibitors. J. Virol. 87 (2013), 13785–13794.
67. Ha, M.N., et al. Mutations in the fusion protein of measles virus that confer resistance to the membrane fusion inhibitors carbobenzoxy-D-Phe-l-Phe-Gly and 4-nitro-2-phenylacetyl amino-benzamide. J. Virol., 91, 2017 pii: e01026-17.
68. Ishizaki, Y., et al. Association of toll-like receptor 3 gene polymorphism with subacute sclerosing panencephalitis. J. Neurovirol. 14 (2008), 486–491.
69. Takeda, M., et al. Recovery of pathogenic measles virus from cloned cDNA. J. Virol. 74 (2000), 6643–6647.
70. Parks, C.L., et al. Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage. J. Virol. 75 (2001), 910–920.
71. Cattaneo, R., et al. Mutated and hypermutated genes of persistent measles viruses which caused lethal human brain diseases. Virology 173 (1989), 415–425.
72. Ayata, M., et al. Amino acid substitutions in the heptad repeat A and C regions of the F protein responsible for neurovirulence of measles virus Osaka-1 strain from a patient with subacute sclerosing panencephalitis. Virology 487 (2016), 141–149.
73. Cattaneo, R., et al. Multiple viral mutations rather than host factors cause defective measles virus gene expression in a subacute sclerosing panencephalitis cell line. J. Virol. 62 (1988), 1388–1397.